Why NeoGenomics (NEO) Stock Is Surging Today

Craig-Hallum set a "buy" rating on NeoGenomics (NEO) and increased its price target on the stock to $8 from $5.

Jul 7, 2014 3:12 PM EDT

NEW YORK (TheStreet) -- Craig-Hallum set a "buy" rating on NeoGenomics (NEO) and increased its price target on the stock to $8 from $5.

The stock was up 12.12% to $4.07 at 3:08 p.m. More than 1 million shares had changed hands, compared to the average volume of 270,889.

If you liked this article you might like

In a record year for acquisitions, 18 companies from across the spectrum were singled out by M&A professionals for doing deals that got results.

Lou Whiteman

Nov 30, 2016 2:28 PM EST

These have positive momentum and good growth.

Rev Shark

Jul 14, 2016 12:22 PM EDT

Keep accounts close to highs and don't give back gains.

Rev Shark

Jul 13, 2016 11:06 AM EDT

The merger closed in December, which means enough time is passed to evaluate whether the acquisition was positive or negative.

Robert Wasserman

Jul 6, 2016 10:38 AM EDT

It's unconcerned about rate hikes or the dollar.

James "Rev Shark" DePorre

May 27, 2016 4:18 PM EDT